Graham Number Checker

Date Checked2025-12-21 23:20:38
Graham Number(PB)nan vs (PE)0.00
Over / Under Value Percentage0.00% vs 0.00%
Dividend Yield0.00%
Dividend Date2018-02-14
SymbolVXRT
AssetTypeCommon Stock
NameVaxart Inc
DescriptionVaxart, Inc. is a clinical-stage biotechnology firm based in South San Francisco, California, focused on revolutionizing vaccination through its proprietary oral recombinant protein vaccine platform. The company is developing innovative oral vaccines to target significant unmet medical needs, with an emphasis on viral infections and gastrointestinal diseases, thereby enhancing immunization strategies and patient compliance. Vaxart's strong commitment to research and development positions it as a potential leader in the vaccine arena, dedicated to addressing critical public health challenges with its novel approaches.
CIK72444
ExchangeNASDAQ
CurrencyUSD
CountryUSA
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Address170 HARBOR WAY, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
OfficialSitehttps://vaxart.com
FiscalYearEndDecember
LatestQuarter2025-09-30
MarketCapitalization84021000
EBITDA-40081000
PERatio0
PEGRatioNone
BookValue0.117
DividendPerShareNone
EPS-0.22
RevenuePerShareTTM0.649
ProfitMargin-0.342
OperatingMarginTTM-0.108
ReturnOnAssetsTTM-0.163
ReturnOnEquityTTM-1.065
RevenueTTM148204000
GrossProfitTTM-30876000
DilutedEPSTTM-0.22
QuarterlyEarningsGrowthYOY0
QuarterlyRevenueGrowthYOY13.68
AnalystTargetPrice3.333
AnalystRatingStrongBuy-
AnalystRatingBuy-
AnalystRatingHold-
AnalystRatingSell-
AnalystRatingStrongSell-
TrailingPE-
ForwardPE42.73
PriceToSalesRatioTTM0.567
PriceToBookRatio3.31
EVToRevenue0.507
EVToEBITDA-0.172
Beta0.883
52WeekHigh0.98
52WeekLow0.261
50DayMovingAverage0.364
200DayMovingAverage0.404
SharesOutstanding240060000
SharesFloat237660000
PercentInsiders0.859
PercentInstitutions1.001
ExDividendDate2012-11-09
etoro1
dateChecked2025-12-21 23:20:38
fresh1